A part of Watch Media

MedWatchWednesday4 October 2023

  • Latest
  • Search
  • Log in
  • Pharma & biotech
  • Medtech
  • Hearing health
  • Regulation
  • Other
  • Search
  • Log in
MedWatchWednesday4 October 2023
  • Search
  • Log in
  • Pharma & biotech
  • Medtech
  • Hearing health
  • Regulation
  • Other
Hearing health

Hearing aid market in US grew by 37 percent in 2021

Hearing aid manufacturers have had a good year following one of the worst in their recorded history, as sales in the US have gone up by 37 percent. The progress is mainly driven by the recovery of independent retailers, whereas public sales channel Veterans Affairs still lags behind.
By Albert Rønning-Andersson, translated by Daniel Pedersen

The year 2020 was written into history as a true annus horribilis for hearing aid manufacturers, whose primary customer segment comprises of the oldest part of the population, who largely kept away from audiologist appointments because of the Covid-19 pandemic.

2021 has turned out differently – at least on the private hearing aid market in the US, which is the world’s biggest single market, where sales of hearing aids went up by 37 percent compared to the year before, which was calculated from a total of 4.73 million units sold in 2021.

Already a subscriber?Log in here

Read the whole article

Get access for 14 days for free. No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.

With your free trial you get:

  • Access all locked articles
  • Receive our daily newsletters
  • Access our app
Must contain at least 6 characters
Must contain at least 2 characters
Must contain at least 2 characters

Get full access for you and your coworkers

Start a free company trial today

Share article

Related articles:

  • Photo: Projekt Bear

    Hearing firms urge FDA to increase OTC safety requirements

    For subscribers

  • Hearing aid industry association responds to FDA's proposed OTC regulation

    For subscribers

  • Photo: Demant / PR

    Sonova wins Veterans Affairs market shares in December

    For subscribers

Sign up for our newsletter

Stay ahead of development by receiving our newsletter on the latest sector knowledge.

Newsletter terms

Front page now

Foto: Tom Little
Pharma & biotech

Investment bank: Novo Nordisk's patent victory is a small victory as price negotiations loom

The market’s attention is more focused on public health insurance Medicare’s new price negotiations under the so-called Inflation Reduction Act.
  • Bank downplays importance of patent dispute and FDA notice to Novo Nordisk
  • Jefferies on Novo Nordisk: Little risk of semaglutide patent dispute - but could raise concerns

For subscribers



Foto: Tom Little
Pharma & biotech

FDA approves Novo Nordisk drug to treat rare condition

For subscribers



Fujifilm Diosynth Biotechnologies' factory in Hillerød, Denmark. | Foto: Liselotte Plenov / Fotorummet / Pr
Pharma & biotech

Fujifilm expands management with former Leo executive

For subscribers


Foto: Andrew Kelly/Reuters/Ritzau Scanpix
Pharma & biotech

Low share price may knock Galecto off the stock exchange

For subscribers


Foto: Mike Segar/Reuters/Ritzau Scanpix
Pharma & biotech

Snack maker keeps an eye on Novo Nordisk's obesity drug


Foto: Yuriko Nakao/Reuters/Ritzau Scanpix
Medtech

Olympus appoints new chief medical officer

For subscribers


  • Foto: Alexander Heinl/AP/Ritzau Scanpix

    Novo Nordisk's semaglutide to be studied for positive effect on alcoholics

    Previous studies have shown that alcohol cravings disappeared when people were treated with GLP-1 agonist exanatide.

    For subscribers


  • Vaccine breakthrough behind mRNA shots wins Nobel Prize

    The two scientists will share the 11 million-krona ( USD 1 million) award, the Nobel Assembly at the Karolinska Institutet in Stockholm said in a statement Monday.

    For subscribers


  • Foto: Ws Audiology / Pr

    WS Audiology hires new chief technology officer from car manufacturer

    He succeeds chief research & development officer Stefan Menzl, who is stepping down after six years.

    For subscribers


  • Foto: Tom Little

    Novo Nordisk files lawsuit against US authorities ahead of price negotiation

    The litigation is the latest in a long line of industry lawsuits related to price negotiations.

    For subscribers


  • Foto: Mike Segar

    FDA rejects atopic dermatitis drug lebrikizumab

    Eli Lilly had expected a launch this year.

    For subscribers


  • The FDA has updated the package label of Novo Nordisk's diabetes drug, Ozempic, with a warning about intestinal blockage disorder as a possible side effect. | Foto: Tom Little/Reuters/Ritzau Scanpix

    FDA updates Novo Nordisk's Ozempic drug label with side effect alert

    The diabetes drug might cause a potentially fatal intestinal blockage, the authorities warn.

    For subscribers


Further reading

Foto: Tom Little
Pharma & biotech

FDA approves Novo Nordisk drug to treat rare condition

The marketing authorization applies to children and adolescents aged 9 years and older, as well as adults with ”relatively” preserved kidney functions.

For subscribers



Fujifilm Diosynth Biotechnologies' factory in Hillerød, Denmark. | Foto: Liselotte Plenov / Fotorummet / Pr
Pharma & biotech

Fujifilm expands management with former Leo executive

The contract manufacturer has hired a chief people officer with immediate effect.

For subscribers



Foto: Mike Segar/Reuters/Ritzau Scanpix
Pharma & biotech

Snack maker keeps an eye on Novo Nordisk's obesity drug

”As with anything that could potentially impact our business, we’re looking at it,” says the former Kellogg’s CEO.

Foto: Yuriko Nakao/Reuters/Ritzau Scanpix
Medtech

Olympus appoints new chief medical officer

The new medical director is brought in from Medtronic. 

For subscribers



Foto: Ws Audiology / Pr
Hearing health

WS Audiology hires new chief technology officer from car manufacturer

He succeeds chief research & development officer Stefan Menzl, who is stepping down after six years.

For subscribers



Genmab CEO Jan van de Winkel and director general of The Confederation of Danish Industry, Lars Sandahl Sørensen. | Foto: Genmab / PR
Pharma & biotech

Genmab has officially opened its new headquarters

The CEO describes the new premises as a symbol of the company’s commitment to advancing science and innovation.

For subscribers


Jobs

  • Director, Head of Antibody Technology

  • Senior CMC Specialist, Upstream Processing, Genmab

  • Clinical Supply Manager

  • Scientist - Bioanalysis, Biologics

  • VP of Software Development, Perfusion Tech

  • Supply Value Stream (SVS) Project Manager

  • Global Medical Manager

  • Audit & Supplier Manager

  • Qualified Person to AJ Vaccines

  • QA/RA Manager

  • Project Director, HR & ESG

  • Senior QA Specialists (GMP or GCP)

  • Senior Legal Councel

  • Clinical Trial Manager

  • Senior Analytical Scientists

See all jobs

Latest news

  • Investment bank: Novo Nordisk's patent victory is a small victory as price negotiations loom –
  • Novo Nordisk's semaglutide to be studied for positive effect on alcoholics –
  • Olympus appoints new chief medical officer –
  • Low share price may knock Galecto off the stock exchange –
  • Fujifilm expands management with former Leo executive –
  • Snack maker keeps an eye on Novo Nordisk's obesity drug –
  • FDA approves Novo Nordisk drug to treat rare condition –
  • FDA updates Novo Nordisk's Ozempic drug label with side effect alert –
  • FDA rejects atopic dermatitis drug lebrikizumab –
  • FDA to support new orphan drugs through pilot program –
See all

Jobs

  • Director, Head of Antibody Technology

  • Senior CMC Specialist, Upstream Processing, Genmab

  • Clinical Supply Manager

  • Scientist - Bioanalysis, Biologics

  • VP of Software Development, Perfusion Tech

  • Supply Value Stream (SVS) Project Manager

  • Global Medical Manager

  • Audit & Supplier Manager

  • Qualified Person to AJ Vaccines

  • QA/RA Manager

  • Project Director, HR & ESG

  • Senior QA Specialists (GMP or GCP)

  • Senior Legal Councel

  • Clinical Trial Manager

  • Senior Analytical Scientists

See all jobs

Colophon

MedWatch
Search

Sections

  • Pharma & biotech
  • Medtech
  • Hearing health
  • Regulation
  • Other
  • Sitemap
  • RSS feeds

Editor

Mikkel Aabenhus Hemmingsen

mah@medwatch.dk

Tel.: +45 3330 8387

  • About MedWatch

Editor-in-chief

Anders Heering

Publisher

JP/Politiken Media Group Ltd

Banner Advertising

annoncering@infowatch.dk

Tel.: +45 7077 7441

Advertising

Job Advertising

job@infowatch.dk

Tel.: +45 7077 7441

Jobs

Subscription

Try MedWatch or get an offer for a subscription meeting the exact needs of you or your company.

medwatch@infowatch.dk

Tel.: +45 7077 7441

Learn more about subscriptions here

Address

MedWatch

Rådhuspladsen 37

1785 Copenhagen K, Denmark

Tel.: +45 3330 8370

Guidelines

  • Privacy Policy

Copyright © MedWatch — All rights reserved